DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	MATN3; COL1A1; COL3A1; COL5A2; DCN; COL1A2; FGF2; SPARC; COL6A1; COL6A3; VCAN; NID1; COL5A1; LAMA2; PTX3; COL8A1; FBN1; COMP; FBLN2; LOXL1; NID2; CCDC80; FBLN5; ITGA11; MMP2; MMP13;	GO:0030198~extracellular matrix organization	26	230	11.304347826087	0	0	0	0	0	0	0
down	NR2F1; NR4A2; CDK7; POLR2K; GTF2B; TAF9; NR4A3; NRBF2; WWTR1;	GO:0006367~transcription initiation from RNA polymerase II promoter	9	161	5.59006211180124	0.00010019625987978	0.00473366232651552	0.190072304991945	0.194080155387136	0.175930971269892	0.190072304991945	0.0385621621028864
up	ITGAM; CD36; FCGR2B; MYH9; ARHGAP25; IGHG2; IGHV1-2; IGHV3-33; IGHV3-30; IGHG1; IGLC2; IGHV3-7; IGHA2; IGHV3-21; IGHV2-5; TRDC; IGHV3-11; IGHV4-39; IGHV4-4; IGHV3-49; IGHV1-3; IGHV1-46; IGHV4-59; IGHV4-61; IGHV3-15; IGHV1-69-2; IGHG3; IGHV3-13; IGKC; IGHV4-34; IGLC3; IGHV5-51; IGHG4; IGHV1-18; IGHD; IGHV3-23; IGHM;	GO:0006911~phagocytosis, engulfment	37	115	32.1739130434783	0.00010466953081456	0.0455693075519028	0.500215687762785	0.501262383070931	0.500006348701156	0.500215687762785	0.412465892188229
up	MS4A1; CD19; MNDA; NCKAP1L; BTK; LAT2; IGHV4-34; IGHV4-4; IGHV4-61; IGHM; IGHV3-33; IGHV3-11; IGHV3-21; IGHV4-39; IGHV1-69-2; IGHG1; IGHV1-2; IGHV2-5; IGLC3; IGHV3-30; IGHV3-13; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHG4; IGHV1-46; IGHV4-59; IGHG3; IGHV1-18; IGHA2; TRDC; IGHD; IGHV3-15; IGLC2; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	39	125	31.2	0.0001184300256628	0.0472634494082656	0.565858662616896	0.567161392899187	0.565740232591233	0.565858662616896	0.427800242649495
down	EIF3H; EIF4E; PABPC1; EIF2S2; EIF1; EIF3E; RPL26; EIF4G2;	GO:0006413~translational initiation	8	130	6.15384615384615	0.00012971446974741	0.00584318436978452	0.245808920171343	0.251256927900734	0.207024293716867	0.245808920171343	0.0476007385661044
down	GNAS; SCX; TP53INP2; WWTR1;	GO:0001894~tissue homeostasis	4	21	19.047619047619	0.00013771791106964	0.00606271803958873	0.260837723565909	0.266759593741904	0.214702223357578	0.260837723565909	0.04938914094424
down	COL1A1; FOXC1; WWTR1; LEF1; AXIN2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	5	42	11.9047619047619	0.00014655981940625	0.00630858600422038	0.277437738136042	0.283886370189917	0.223208475839767	0.277437738136042	0.0513920722169089
down	COL1A2; MMP13; COMP; AXIN2; SBDS;	GO:0030282~bone mineralization	5	44	11.3636363636364	0.00017901473239345	0.0073776922690665	0.33869587368842	0.346751536646125	0.252314758744165	0.338516858956026	0.0601014068180009
down	AKR1B15; AKR1B10; RDH16; AKR1C3; RDH10;	GO:0042572~retinol metabolic process	5	44	11.3636363636364	0.00017901473239345	0.0073776922690665	0.33869587368842	0.346751536646125	0.252314758744165	0.338516858956026	0.0601014068180009
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; LAT; FOS; IGKV1-39; IGKV1-17; IGKV1-5; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-1; IGLV3-25; IGHV1-46; IGHV3-11; IGHV3-23; IGHV3-13; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; IGHV1-2; PSMB9; PSMB10; VAV2; LILRA4; MS4A2; BTK; TAB1; LAT2;	GO:0038095~Fc-epsilon receptor signaling pathway	48	171	28.0701754385965	0.00018026319139519	0.0664061864301209	0.861117265294829	0.863280423591571	0.860937002103434	0.861117265294829	0.601068754479548
down	S1PR1; MT-RNR2; SBDS; CXCL2;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.00021730564278454	0.00876918812653481	0.410707664862797	0.420921030073671	0.282977409816094	0.410707664862797	0.071437046143311
up	IGHG3; IGHV3-49; IGHV1-69-2; IGHG4; IGLC3; IGHV3-15; IGHV4-39; IGHV3-21; IGHD; IGHV4-59; IGHV4-4; IGHV3-23; IGHM; IGHG1; IGHV3-13; IGHV1-2; IGHV1-18; IGHV3-11; IGHG2; IGHV3-33; IGLC2; IGHV1-46; IGHV5-51; IGHV4-61; IGHV1-3; IGHV4-34; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV2-5;	GO:0050871~positive regulation of B cell activation	32	98	32.6530612244898	0.00023770707081416	0.0813127972949307	1	1	0.999999975761346	0.999999975761346	0.735994406857599
down	COL3A1; SPARC; BCL2L1; TIMP3; TIMP2;	GO:0034097~response to cytokine	5	48	10.4166666666667	0.00026009157646145	0.0102815792572619	0.491312987935683	0.503797383605832	0.313612853990882	0.491312987935683	0.0837575430278016
down	CYTIP; S1PR1; LAMA2; CXCR4; PPP2CA;	GO:0030155~regulation of cell adhesion	5	49	10.2040816326531	0.00028412432404556	0.0108611175603161	0.536426723798026	0.550348815676259	0.328666944722212	0.536426723798026	0.0884786761475059
down	SNX3; PPP2CA; LEF1; DACT1;	GO:0030111~regulation of Wnt signaling pathway	4	26	15.3846153846154	0.00028596644066913	0.0108611175603161	0.539618673542665	0.553916995576122	0.329719306091517	0.539618673542665	0.0884786761475059
down	MB; COL1A1; FYN; PPP2CB; NR4A3;	GO:0042542~response to hydrogen peroxide	5	50	10	0.00030980368332278	0.0113224478225705	0.584289746746772	0.600089734596234	0.342642873755	0.583979943063449	0.0922368428964033
down	FGF2; CCR7; RASA3; PLCL1; PLCD3;	GO:0051209~release of sequestered calcium ion into cytosol	5	50	10	0.00030980368332278	0.0113224478225705	0.584289746746772	0.600089734596234	0.342642873755	0.583979943063449	0.0922368428964033
down	EIF3H; EIF1; EIF3E; EIF4G2;	GO:0006446~regulation of translational initiation	4	28	14.2857142857143	0.00036893385308256	0.0129931795167441	0.695071379207552	0.714624873420928	0.372254257760308	0.694702445354469	0.105847240507629
down	HSBP1; MMP2; COL6A1; COL8A1;	GO:0035987~endodermal cell differentiation	4	28	14.2857142857143	0.00036893385308256	0.0129931795167441	0.695071379207552	0.714624873420928	0.372254257760308	0.694702445354469	0.105847240507629
down	CTHRC1; FBLN5; HPSE;	GO:0033690~positive regulation of osteoblast proliferation	3	12	25	0.00050494625882546	0.0171593140937707	0.949803912850704	0.97808090334493	0.428194427483996	0.949803912850704	0.139786111897299
down	COL1A1; MMP2; SCX; LEF1;	GO:0060325~face morphogenesis	4	31	12.9032258064516	0.00052372578684023	0.0174906353294747	0.984604479259641	1	0.434168677290554	0.984604479259641	0.142485177085744
down	TGFA; BMP6; NME2; OSR2; NR4A3;	GO:0050679~positive regulation of epithelial cell proliferation	5	57	8.7719298245614	0.00054195195222106	0.0177925581602068	1	1	0.43974556735379	0.99099425631235	0.144944752006421
down	BMP6; CHI3L1; ZEB1; GNAS; IL17F;	GO:0051216~cartilage development	5	58	8.62068965517241	0.00058353526564525	0.0188384634925809	1	1	0.451656295609425	0.99099425631235	0.153465083240307
down	TGFA; FYN; FGF2; CD28; CCR7; CHI3L1; AKR1C3; HPSE;	GO:0051897~positive regulation of protein kinase B signaling	8	165	4.84848484848485	0.00059661186495496	0.0189448718429142	1	1	0.455214852960639	0.99099425631235	0.154331924973329
down	FYN; CXCR4; PHF24;	GO:0050966~detection of mechanical stimulus involved in sensory perception of pain	3	13	23.0769230769231	0.00061653627011526	0.0189560437335439	1	1	0.460552593776102	0.99099425631235	0.154422935321711
down	COL3A1; COL5A1; LTBP2;	GO:0097435~supramolecular fiber organization	3	13	23.0769230769231	0.00061653627011526	0.0189560437335439	1	1	0.460552593776102	0.99099425631235	0.154422935321711
down	MT2A; UCHL1; CXCR4; GPLD1; PDE4B;	GO:0035690~cellular response to drug	5	59	8.47457627118644	0.00062746554279302	0.0189906368185952	1	1	0.463290163856074	0.99099425631235	0.154704743372512
down	DCN; VCAN; HYAL4;	GO:0030207~chondroitin sulfate catabolic process	3	14	21.4285714285714	0.00074270822562105	0.0202623356764506	1	1	0.492850557173902	0.99099425631235	0.165064472081503
down	FYN; MMP2; MMP13;	GO:1904645~response to amyloid-beta	3	14	21.4285714285714	0.00074270822562105	0.0202623356764506	1	1	0.492850557173902	0.99099425631235	0.165064472081503
down	KLK8; BCL10; EIF4G2; VAPA;	GO:0008219~cell death	4	35	11.4285714285714	0.00079536272076064	0.0213974665293522	1	1	0.505882145545396	0.99099425631235	0.174311667368836
down	AKR1B10; AKR1C3; GPIHBP1; RDH10; GPC6;	GO:0001523~retinoid metabolic process	5	63	7.93650793650794	0.00082833746477095	0.0217374206682886	1	1	0.514397565622764	0.99099425631235	0.177081059376327
down	BCL10; FYN; PSMC6; PDE4B; ITK; TAB2; FBXW11; CD28;	GO:0050852~T cell receptor signaling pathway	8	174	4.59770114942529	0.00083044353611427	0.0217374206682886	1	1	0.514874992390852	0.99099425631235	0.177081059376327
down	PPP2CB; PPP2CA; PPP2R2C;	GO:0070262~peptidyl-serine dephosphorylation	3	15	20	0.00088417875732038	0.0225627752591333	1	1	0.527408806648433	0.99099425631235	0.183804702790061
down	TGFA; NSF; STX5; MCFD2; RAB1B;	GO:0048208~COPII vesicle coating	5	64	7.8125	0.00088527151249051	0.0225627752591333	1	1	0.527621821444347	0.99099425631235	0.183804702790061
down	DCN; SPARC; S100A7; CCR7; LOXL1; AKIRIN2; TAB2;	GO:0032496~response to lipopolysaccharide	7	138	5.07246376811594	0.00101025186307291	0.0250879212663106	1	1	0.548566761648589	0.99099425631235	0.204375475047469
down	CRLF1; SOD2; FYN; NR4A2; BCL2L1; NR4A3; NGF;	GO:0043524~negative regulation of neuron apoptotic process	7	138	5.07246376811594	0.00101025186307291	0.0250879212663106	1	1	0.548566761648589	0.99099425631235	0.204375475047469
down	EIF3H; EIF3E; EIF2S2;	GO:0001732~formation of cytoplasmic translation initiation complex	3	16	18.75	0.00104163646376065	0.0252206228788048	1	1	0.553108962256907	0.99099425631235	0.205456511407764
down	IL7R; CDH2; CCR7;	GO:0048872~homeostasis of number of cells	3	16	18.75	0.00104163646376065	0.0252206228788048	1	1	0.553108962256907	0.99099425631235	0.205456511407764
up	IGLV4-69; IGLV8-61; IGLV1-50; IGLV3-10; TRGV2; IGKV2D-29; IGKV1-27; TRAJ3; TRAJ42; IGKV3D-15; IGKV1D-8; IGKV3D-11; IGLV5-52; TRAV8-3; TRGV5; TRAV8-2; TRGV8; TRGV4; IGKV3D-7; IGKV2-24; IGKV1-9; IGKV1-6; TRBJ1-6; TRDV1; TNFRSF13B; LAT; LILRA1; LILRB5; CD160; JCHAIN; CD4; IGHM; HLA-B; TRGV3; TRGC2; CD3D; CD7; CD3G; TRGC1; HLA-C; CD8B; CD1E; TFEB; CTSS; HLA-DMA; HLA-DMB; CD1C; CD79B; CD86; TNFRSF17; BTK; SLAMF1; ADGRE1; LAIR1; ERAP2; SKAP1; CLEC10A; LAX1; ZNF683; LILRB2; LILRB4; LILRB1; TRPM4; CLEC4C; TSC1; FCGR1B; ORAI1; SIGLEC10; FCRL4; TNFRSF13C; TRGV9; PDCD1LG2; CD244; LAT2; UNC93B1; CD209; CD84; SIT1;	GO:0002250~adaptive immune response	78	347	22.478386167147	0.00104336195631538	0.312291275549647	1	1	0.999999975761346	0.999999975761346	1
down	KRT75; CASP14; KRT20; TGM3; KRT32; LCE1C; KRT77; KRTAP4-8;	GO:0031424~keratinization	8	181	4.41988950276243	0.00105897135156852	0.0253237963949162	1	1	0.555959959573471	0.99099425631235	0.206297000986145
down	BCL10; FYN; CCR7; S100A12; CASP10; TAB2; PLK2; VAPA;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	8	183	4.37158469945355	0.00113273296335137	0.0255128343024605	1	1	0.565233748712333	0.99099425631235	0.207836973618641
down	SNX17; RAB17; RAB35; SNX3;	GO:0032456~endocytic recycling	4	39	10.2564102564103	0.00115376155288471	0.0256877715854907	1	1	0.567661353707375	0.99099425631235	0.20926207735455
down	COL6A1; MATN3; COL6A3;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	3	17	17.6470588235294	0.00121574254359369	0.0264594753588874	1	1	0.575519243848263	0.99099425631235	0.215548661388743
down	PPIF; PPP2CB; BCL2L1;	GO:0008637~apoptotic mitochondrial changes	3	17	17.6470588235294	0.00121574254359369	0.0264594753588874	1	1	0.575519243848263	0.99099425631235	0.215548661388743
down	RALB; ADD2; CTHRC1; DACT1; PLK2;	GO:0032092~positive regulation of protein binding	5	70	7.14285714285714	0.00129007737760667	0.0268696761335927	1	1	0.58456476463309	0.99099425631235	0.21889030844293
down	SNAPC5; CDK7; POLR2K; GTF2B; TAF9;	GO:0042795~snRNA transcription by RNA polymerase II	5	70	7.14285714285714	0.00129007737760667	0.0268696761335927	1	1	0.58456476463309	0.99099425631235	0.21889030844293
down	CD28; PABPC1; EIF3E; RPL26; RBM3;	GO:0045727~positive regulation of translation	5	70	7.14285714285714	0.00129007737760667	0.0268696761335927	1	1	0.58456476463309	0.99099425631235	0.21889030844293
down	NME2; NME7; AK5;	GO:0006165~nucleoside diphosphate phosphorylation	3	18	16.6666666666667	0.00140713141781568	0.0286906690137786	1	1	0.598867540848711	0.99099425631235	0.233724789187487
down	RALB; KRT20; AKR1C3; FOXA3; MAP1LC3B;	GO:0009267~cellular response to starvation	5	72	6.94444444444444	0.00145126033420184	0.0292822007015518	1	1	0.604039526890966	0.99099425631235	0.238543624849915
down	MB; ACAT1; TIMP3; TIMP2;	GO:0009725~response to hormone	4	42	9.52380952380952	0.00148753329765505	0.0297046597686375	1	1	0.608401118740917	0.99099425631235	0.241985132482502
down	SPARC; PPP2CB; PPP2CA;	GO:0010288~response to lead ion	3	19	15.7894736842105	0.00161641134004675	0.0307791210694531	1	1	0.617583179291108	0.99099425631235	0.250738091184952
down	PLA2G2A; PLBD1; PLA2G4D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	3	19	15.7894736842105	0.00161641134004675	0.0307791210694531	1	1	0.617583179291108	0.99099425631235	0.250738091184952
down	PPP2CB; NRBF2; DNAJB9; UFC1; ERP27;	GO:0034976~response to endoplasmic reticulum stress	5	74	6.75675675675676	0.00162679499062846	0.0307791210694531	1	1	0.618197940615141	0.99099425631235	0.250738091184952
down	NSF; RAB7A; STX5; DACT1; PLK2;	GO:0045732~positive regulation of protein catabolic process	5	74	6.75675675675676	0.00162679499062846	0.0307791210694531	1	1	0.618197940615141	0.99099425631235	0.250738091184952
down	TGFA; ARF4; NSF; CAPZB; STX5; MCFD2; RAB1B; VAPA;	GO:0006888~endoplasmic reticulum to Golgi vesicle-mediated transport	8	196	4.08163265306122	0.0017178515567543	0.0313913062776706	1	1	0.623714903008493	0.99099425631235	0.255725178055098
down	KLK8; SPARC; SLITRK4;	GO:0050807~regulation of synapse organization	3	21	14.2857142857143	0.00209095009339832	0.0377516690956066	1	1	0.644121773104546	0.99099425631235	0.307539043324817
up	LILRA1; LILRB5; OR2H2; HP; HLA-B; MX1; FCGR2B; WAS; CXCL9; TPSAB1; CEBPE; ACKR1; COLEC12; LILRA2; CLEC1A; IL31RA; RNASE6; P2RY11; IL17RB; CD84; NOD1; DUOX1; NOX4;	GO:0006952~defense response	23	72	31.9444444444444	0.00211082129737972	0.593148608910101	1	1	0.999999975761346	0.999999975761346	1
down	TAX1BP3; TRABD2A; DACT1; CTNNBIP1;	GO:0030178~negative regulation of Wnt signaling pathway	4	47	8.51063829787234	0.00218414666225364	0.0377516690956066	1	1	0.649311668462307	0.99099425631235	0.307539043324817
down	ADAMTS2; ARG1; EIF4E; SPARC; CHI3L1;	GO:0030324~lung development	5	80	6.25	0.002247024525178	0.0377516690956066	1	1	0.652843982537556	0.99099425631235	0.307539043324817
down	FBN1; ITGA11; ITGBL1;	GO:0033627~cell adhesion mediated by integrin	3	22	13.6363636363636	0.00235729993647693	0.0380507498079651	1	1	0.657686682277064	0.99099425631235	0.309975465299239
down	FGF2; CXCL2; S1PR1; PLGRKT; CXCR4; CCR7;	GO:0006935~chemotaxis	6	122	4.91803278688525	0.00265365650354688	0.0421322348145106	1	1	0.67081902236381	0.99099425631235	0.343224750015068
down	NR2F1; NR4A2; NR4A3; LEF1;	GO:0043401~steroid hormone mediated signaling pathway	4	52	7.69230769230769	0.00307814308008392	0.0465809620790824	1	1	0.689504049938797	0.99099425631235	0.379465725837741
down	HYAL4; HPSE; GPC6;	GO:0006027~glycosaminoglycan catabolic process	3	25	12	0.00327871680346281	0.0481126852144505	1	1	0.698366679137579	0.99099425631235	0.391943708373999
down	CNKSR2; TSPYL2; GPC6;	GO:0009966~regulation of signal transduction	3	25	12	0.00327871680346281	0.0481126852144505	1	1	0.698366679137579	0.99099425631235	0.391943708373999
down	ARG1; TCF7; LEF1;	GO:0071353~cellular response to interleukin-4	3	25	12	0.00327871680346281	0.0481126852144505	1	1	0.698366679137579	0.99099425631235	0.391943708373999
down	SPARC; ETS1; GPLD1; ADGRA2;	GO:0010595~positive regulation of endothelial cell migration	4	54	7.40740740740741	0.00349653260299554	0.0509231853534012	1	1	0.707505870729345	0.99099425631235	0.414839080809274
down	PLA2G2A; PLBD1; PLA2G4D;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	3	26	11.5384615384615	0.00362819027709382	0.0520578116054129	1	1	0.712226350752658	0.99099425631235	0.424082165431339
down	TIMP2; PPP2CB; RASA3;	GO:0046580~negative regulation of Ras protein signal transduction	3	26	11.5384615384615	0.00362819027709382	0.0520578116054129	1	1	0.712226350752658	0.99099425631235	0.424082165431339
down	COMP; LTBP2; RCN3; RAB3B;	GO:0009306~protein secretion	4	56	7.14285714285714	0.00395194938642129	0.0545572211828629	1	1	0.723658712261515	0.99099425631235	0.444443279224194
down	GPIHBP1; CD177; FBLN5;	GO:0034394~protein localization to cell surface	3	27	11.1111111111111	0.00399954848113915	0.0545572211828629	1	1	0.725598238291996	0.99099425631235	0.444443279224194
down	PLA2G2A; PLBD1; PLA2G4D;	GO:0036151~phosphatidylcholine acyl-chain remodeling	3	27	11.1111111111111	0.00399954848113915	0.0545572211828629	1	1	0.725598238291996	0.99099425631235	0.444443279224194
down	CDH2; PSMC6; CTHRC1; WWTR1; DACT1; DKK2; AXIN2;	GO:0090090~negative regulation of canonical Wnt signaling pathway	7	179	3.91061452513966	0.00411120259539466	0.0556881078830731	1	1	0.729641193961167	0.99099425631235	0.453655900075755
down	PLA2G2A; PLBD1; PLA2G4D; PLAA;	GO:0006644~phospholipid metabolic process	4	57	7.01754385964912	0.00419400665808567	0.0564152145604996	1	1	0.732826112276089	0.99099425631235	0.459579179690347
down	SOD2; GPX2; NME2; NR4A2; MSRA;	GO:0034599~cellular response to oxidative stress	5	94	5.31914893617021	0.00433827434833811	0.0579533614671098	1	1	0.737506639217479	0.99099425631235	0.472109492640324
down	SPARC; CAPZB; ARC;	GO:0022604~regulation of cell morphogenesis	3	28	10.7142857142857	0.00439318985788661	0.0579923469969669	1	1	0.739626990482389	0.99099425631235	0.472427083169246
down	MMP2; S1PR1; SAT1; COL8A1; S100A7; FOXC1; PDE3B; PLCD3;	GO:0001525~angiogenesis	8	230	3.47826086956522	0.00440107124860822	0.0579923469969669	1	1	0.739626990482389	0.99099425631235	0.472427083169246
down	RAB7A; TP53INP2; RAB1B; MAP1LC3B;	GO:0000045~autophagosome assembly	4	59	6.77966101694915	0.0047077258717857	0.0604083631324707	1	1	0.749636123010627	0.99099425631235	0.492108843175365
down	FBN1; RDH10; OSR2;	GO:0001656~metanephros development	3	29	10.3448275862069	0.00480949220322269	0.0604083631324707	1	1	0.753234376401078	0.99099425631235	0.492108843175365
down	TIMP2; FOXC1; CDKN1C;	GO:0045930~negative regulation of mitotic cell cycle	3	29	10.3448275862069	0.00480949220322269	0.0604083631324707	1	1	0.753234376401078	0.99099425631235	0.492108843175365
down	TCF7; LEF1; AXIN2;	GO:1904837~beta-catenin-TCF complex assembly	3	29	10.3448275862069	0.00480949220322269	0.0604083631324707	1	1	0.753234376401078	0.99099425631235	0.492108843175365
down	ATP6V1G1; BMP6; MT-RNR2; ABCG2;	GO:0006879~cellular iron ion homeostasis	4	60	6.66666666666667	0.00497974322686112	0.0610491305723417	1	1	0.758309598814056	0.99099425631235	0.497328771463902
down	BMP6; GNAS; CTHRC1; CTNNBIP1;	GO:0045669~positive regulation of osteoblast differentiation	4	60	6.66666666666667	0.00497974322686112	0.0610491305723417	1	1	0.758309598814056	0.99099425631235	0.497328771463902
down	NGF; CEBPG; FOXC1;	GO:0043388~positive regulation of DNA binding	3	30	10	0.00524881316361969	0.0634725896074879	1	1	0.76658441796565	0.99099425631235	0.517071164080192
down	TPRG1L; CDH2; DGKI;	GO:0051966~regulation of synaptic transmission, glutamatergic	3	30	10	0.00524881316361969	0.0634725896074879	1	1	0.76658441796565	0.99099425631235	0.517071164080192
down	UCHL1; BCL2L1; FOXC1; OGFOD1; GNL3; AXIN2;	GO:0008283~cell population proliferation	6	142	4.22535211267606	0.0053948308143893	0.0645048597992103	1	1	0.771460806457669	0.99099425631235	0.525480418421002
up	P2RY2; P2RY1; P2RY4; TRPV1; TRPM4; P2RY11; P2RX4; P2RX7; P2RY12;	GO:0071318~cellular response to ATP	9	18	50	0.00545308283638191	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	EIF4E; RPA2; CDK7; BCAT1; PLK2;	GO:0000082~G1/S transition of mitotic cell cycle	5	100	5	0.00556019686736275	0.0660742413011144	1	1	0.775720647787651	0.99099425631235	0.538265179923466
down	MB; COL3A1; SPARC; FBN1; FOXC1; MTERF4; TAB2;	GO:0007507~heart development	7	190	3.68421052631579	0.00560101760935405	0.0661534823738951	1	1	0.776819266931685	0.99099425631235	0.538910706976939
down	COL1A1; PSMC6; ADGRA2; DACT1; DKK2; AXIN2;	GO:0090263~positive regulation of canonical Wnt signaling pathway	6	144	4.16666666666667	0.00575244380131867	0.0664911825658759	1	1	0.780231791883508	0.99099425631235	0.541661737499837
up	CCL5; CCR1; CCR2; CXCR3; CCR6; GPR17; ACKR1; CMKLR1; GPR35; CCL26; CCL16; CCL11; CCL4; CCL13; CXCL9; CCL24; CCL14; TFF2; XCL2; XCL1; CCL18;	GO:0070098~chemokine-mediated signaling pathway	21	70	30	0.00583557420655356	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	DGKI; COL1A1; COL3A1; FYN; COL1A2;	GO:0030168~platelet activation	5	102	4.90196078431373	0.00601645247657878	0.0669762554432937	1	1	0.786340632846649	0.99099425631235	0.545613320363262
down	COL1A1; FYN; COL1A2; ADD2; PDE4B; GRB14; CD177;	GO:0050900~leukocyte migration	7	193	3.62694300518135	0.00606965460431452	0.0670682861526471	1	1	0.787630911405218	0.99099425631235	0.546363036521226
down	PPP2CA; TIMP3; TIMP2;	GO:0010033~response to organic substance	3	32	9.375	0.00619784368679599	0.0670682861526471	1	1	0.790285198725705	0.99099425631235	0.546363036521226
down	NR2F1; NR4A2; NR4A3;	GO:0030522~intracellular receptor signaling pathway	3	32	9.375	0.00619784368679599	0.0670682861526471	1	1	0.790285198725705	0.99099425631235	0.546363036521226
down	FHIT; TAF9; TRIM39;	GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process	3	32	9.375	0.00619784368679599	0.0670682861526471	1	1	0.790285198725705	0.99099425631235	0.546363036521226
down	FGF2; ETS1; ADGRA2;	GO:0045765~regulation of angiogenesis	3	32	9.375	0.00619784368679599	0.0670682861526471	1	1	0.790285198725705	0.99099425631235	0.546363036521226
down	PABPC1; CSTF2; PAF1;	GO:0006378~mRNA polyadenylation	3	33	9.09090909090909	0.00670817214151387	0.071003986000614	1	1	0.801669175635999	0.99099425631235	0.578424701476808
down	COL1A2; OSR2; AXIN2;	GO:0042476~odontogenesis	3	33	9.09090909090909	0.00670817214151387	0.071003986000614	1	1	0.801669175635999	0.99099425631235	0.578424701476808
down	ETS1; CHI3L1; TAF9;	GO:0070555~response to interleukin-1	3	33	9.09090909090909	0.00670817214151387	0.071003986000614	1	1	0.801669175635999	0.99099425631235	0.578424701476808
down	MMP2; FGF2; NR4A3;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	3	33	9.09090909090909	0.00670817214151387	0.071003986000614	1	1	0.801669175635999	0.99099425631235	0.578424701476808
down	MATN3; STC2; MMP2; VCAN; CDH2; FBN1; MMP13;	GO:0044267~cellular protein metabolic process	7	200	3.5	0.00727630430199777	0.0737916305391083	1	1	0.806339093163975	0.99099425631235	0.601133883747055
down	SULT1B1; PGK1; TAGLN; PIH1D1;	GO:0030855~epithelial cell differentiation	4	68	5.88235294117647	0.0075420836443727	0.0760886250997392	1	1	0.808082529041087	0.99099425631235	0.619846050033259
down	NR4A2; LEF1; NID1; TCF7;	GO:0060070~canonical Wnt signaling pathway	4	70	5.71428571428571	0.00829584159153574	0.0799454983224115	1	1	0.81400254756886	0.99099425631235	0.651265564177703
down	SNAP29; VAMP3; VAPA;	GO:0061025~membrane fusion	3	36	8.33333333333333	0.00838574027103478	0.0801324045726605	1	1	0.81473341405377	0.99099425631235	0.652788171542358
down	DCN; FGF2; COMP; ATRNL1; LAMA2;	GO:0009887~animal organ morphogenesis	5	111	4.5045045045045	0.00839797528562214	0.0801324045726605	1	1	0.81473341405377	0.99099425631235	0.652788171542358
up	ST8SIA6; CHST9; CHST14; CHST8; CHST11; CHST12;	GO:0016051~carbohydrate biosynthetic process	6	9	66.6666666666667	0.00844858457313158	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	BCL10; FYN; PSMC6; TAB2; FBXW11;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	5	112	4.46428571428571	0.00869752248546019	0.0825838286977273	1	1	0.817567113633257	0.99099425631235	0.672758378112487
down	CRLF1; ARG2; FOXC1;	GO:0001657~ureteric bud development	3	37	8.10810810810811	0.00899461327253115	0.0845755626645283	1	1	0.819484046205688	0.99099425631235	0.688983778826725
down	GPLD1; SCX; OSR2;	GO:0002062~chondrocyte differentiation	3	37	8.10810810810811	0.00899461327253115	0.0845755626645283	1	1	0.819484046205688	0.99099425631235	0.688983778826725
down	FGF2; RIT1; PLK2; RALB;	GO:0007265~Ras protein signal transduction	4	73	5.47945205479452	0.00951624916578298	0.0873804035156219	1	1	0.823994140020799	0.99099425631235	0.711833048612364
down	VAMP3; SNAP29; STX5;	GO:0006906~vesicle fusion	3	38	7.89473684210526	0.00962869734375704	0.0875623791307859	1	1	0.824965544842515	0.99099425631235	0.713315489202056
down	BCL10; ARG1; PDE4B; PAF1; PLAA; CXCL2;	GO:0071222~cellular response to lipopolysaccharide	6	163	3.68098159509202	0.0100604375869968	0.0910610635794992	1	1	0.828035184079138	0.99099425631235	0.741817065265562
down	PABPC1; EIF3E; RPL26; ETF1; PPP2CA;	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	5	117	4.27350427350427	0.0103064482486921	0.0928539081754259	1	1	0.830221776412075	0.99099425631235	0.75642223968752
down	COL5A2; SPARC; GPLD1; COL1A1;	GO:0001503~ossification	4	76	5.26315789473684	0.0108476994908178	0.0956041307599365	1	1	0.834975238005417	0.99099425631235	0.778826568895552
down	TGFA; FGF2; CXCR4; PEA15; TAB2;	GO:0000187~activation of MAPK activity	5	122	4.0983606557377	0.0121081253328538	0.104266360837602	1	1	0.844769668949762	0.99099425631235	0.849392295258493
down	BCL10; COL1A1; BMP6; SCX;	GO:0071260~cellular response to mechanical stimulus	4	79	5.06329113924051	0.0122936899415282	0.104266360837602	1	1	0.846352375589481	0.99099425631235	0.849392295258493
down	FBN1; FOXC1; MTERF4;	GO:0043010~camera-type eye development	3	42	7.14285714285714	0.0124208555101271	0.104266360837602	1	1	0.846352375589481	0.99099425631235	0.849392295258493
down	COL1A1; FYN; COL1A2; RAB5A; CAPZB; CD177;	GO:0007596~blood coagulation	6	171	3.50877192982456	0.0124245059762423	0.104266360837602	1	1	0.846352375589481	0.99099425631235	0.849392295258493
down	BCL10; PSMC6; PPP3R1; ITK; TAB2; FBXW11;	GO:0038095~Fc-epsilon receptor signaling pathway	6	171	3.50877192982456	0.0124245059762423	0.104266360837602	1	1	0.846352375589481	0.99099425631235	0.849392295258493
down	COL1A1; COL1A2; COL5A1;	GO:0001568~blood vessel development	3	43	6.97674418604651	0.0131836454317805	0.108666898729187	1	1	0.853238537811414	0.99099425631235	0.885240702645861
down	ADAMTS2; MMP2; MMP13;	GO:0030574~collagen catabolic process	3	43	6.97674418604651	0.0131836454317805	0.108666898729187	1	1	0.853238537811414	0.99099425631235	0.885240702645861
up	IL18RAP; IL18BP; PDGFB; ALOX5; IL18R1;	GO:0035655~interleukin-18-mediated signaling pathway	5	7	71.4285714285714	0.0133044246493004	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	PLA2G2A; RAB7A; PLBD1; PLCD3;	GO:0016042~lipid catabolic process	4	81	4.93827160493827	0.013322925943039	0.10888821751758	1	1	0.853238537811414	0.99099425631235	0.887043647259513
down	NGF; TIMP2; BMP6; ZEB1;	GO:0045666~positive regulation of neuron differentiation	4	81	4.93827160493827	0.013322925943039	0.10888821751758	1	1	0.853238537811414	0.99099425631235	0.887043647259513
down	COL3A1; DCN; FGF2; SPARC;	GO:0042060~wound healing	4	82	4.8780487804878	0.0138574566803114	0.111086542989829	1	1	0.859072647471663	0.99099425631235	0.904952018699721
down	SULT1B1; RDH16; AKR1C3;	GO:0008202~steroid metabolic process	3	44	6.81818181818182	0.013972602505558	0.111086542989829	1	1	0.859072647471663	0.99099425631235	0.904952018699721
up	NCR3; CD5L; IL18RAP; KNG1; FOS; CALCA; CSF1R; ADORA3; CYBA; CCL5; FOLR2; ALOX15; SELE; ITGAL; PTAFR; FCGR2B; CNR2; IL13; CXCR3; CSRP3; TIRAP; NLRP6; LYZ; HSPG2; MS4A2; NAIP; IL18R1; TCIRG1; NFE2L1; AGER; THEMIS2; DAB2IP; CERS6; TRIL; NRROS; NFKBID; PLD4; CD180; P2RX7; SIGLEC1; NLRP1; NOX4; NLRC4; NLRP2; STAB1; ADGRE2; PLA2G4C; NOD1; MFHAS1; CHST2; LAT; CCL11; PTGDR; ACKR1; CCL16; CCL24; PTGER1; CCL14; C3AR1; CCL26; TNFRSF4; CXCL9; TLR4; CCL4; CMKLR1; CCL13; XCL1; CCL18; CIITA; TAC4; FPR3; CCR1; CCR2; GGT5; XCL2; HRH4;	GO:0006954~inflammatory response	76	381	19.9475065616798	0.0145220446152237	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	ARF4; NSF; RINT1; RAB1B;	GO:0006890~retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum	4	85	4.70588235294118	0.015541971331799	0.113335349838901	1	1	0.870383676404798	0.99099425631235	0.923271630085233
down	BMP6; COMP; SCX; LEF1;	GO:0030509~BMP signaling pathway	4	85	4.70588235294118	0.015541971331799	0.113335349838901	1	1	0.870383676404798	0.99099425631235	0.923271630085233
down	PPIF; FKBP3; FKBP10;	GO:0000413~protein peptidyl-prolyl isomerization	3	46	6.52173913043478	0.0156294410715554	0.113335349838901	1	1	0.872928657914754	0.99099425631235	0.923271630085233
down	FOXC1; AXIN2; LEF1;	GO:0001756~somitogenesis	3	46	6.52173913043478	0.0156294410715554	0.113335349838901	1	1	0.872928657914754	0.99099425631235	0.923271630085233
down	CDH2; SCARF2; TENM1;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	3	47	6.38297872340426	0.0164975009945167	0.113335349838901	1	1	0.878350575044659	0.99099425631235	0.923271630085233
down	STC2; COL1A1; SPARC;	GO:0043434~response to peptide hormone	3	47	6.38297872340426	0.0164975009945167	0.113335349838901	1	1	0.878350575044659	0.99099425631235	0.923271630085233
up	GCM2; PTH; PKHD1; CALCB; CCL5; DRD5; KEL; CCR1; CHRNA7; CASR; CCR2; CSRP3; CCL11; GRIK2; TCIRG1; RGN; CCL14; CHERP; TPCN2; ATP2A3; CCL13; ATP2A1; ATP13A5; ATP2C2;	GO:0006874~cellular calcium ion homeostasis	24	94	25.531914893617	0.0166874140436909	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	TIMP2; ZEB1; DNER; ADGRA2; VCAN;	GO:0007417~central nervous system development	5	133	3.7593984962406	0.0167970841824626	0.113335349838901	1	1	0.881242264180609	0.99099425631235	0.923271630085233
down	TGFA; CLTA; IL7R; RAB5A; VAMP3;	GO:0061024~membrane organization	5	134	3.73134328358209	0.0172751955483864	0.113335349838901	1	1	0.884265393731829	0.99099425631235	0.923271630085233
down	EIF4E; EIF4G2; TAB2;	GO:0010507~negative regulation of autophagy	3	48	6.25	0.0173920856403318	0.113335349838901	1	1	0.886996367656921	0.99099425631235	0.923271630085233
down	COL6A3; LAMA2; TAGLN; ITGA11;	GO:0007517~muscle organ development	4	89	4.49438202247191	0.0179804581365701	0.113335349838901	1	1	0.890743528484443	0.99099425631235	0.923271630085233
down	DCN; TP53INP2; PLK2;	GO:0010508~positive regulation of autophagy	3	49	6.12244897959184	0.0183132527571153	0.113335349838901	1	1	0.894219600790724	0.99099425631235	0.923271630085233
down	PPP2CB; PPP3R1; PPP2CA; FBXW11; PTPRH;	GO:0006470~protein dephosphorylation	5	137	3.64963503649635	0.0187633192668086	0.113335349838901	1	1	0.897869476712318	0.99099425631235	0.923271630085233
down	TGFA; PIGR; ARF4;	GO:0007173~epidermal growth factor receptor signaling pathway	3	50	6	0.0192610481202158	0.113335349838901	1	1	0.901706525758098	0.99099425631235	0.923271630085233
up	PTH; PTAFR; ADCYAP1R1; AVPR1B; CD244;	GO:0060732~positive regulation of inositol phosphate biosynthetic process	5	8	62.5	0.0193389773453534	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	PABPC1; CSTF2; POLR2K; IK; PCBP1; ZMAT2; DHX35;	GO:0000398~mRNA splicing, via spliceosome	7	246	2.84552845528455	0.019997418795945	0.113335349838901	1	1	0.905745524753655	0.99099425631235	0.923271630085233
down	EIF4E; PAF1; GNL3;	GO:0019827~stem cell population maintenance	3	51	5.88235294117647	0.0202355058627743	0.113335349838901	1	1	0.908713629785682	0.99099425631235	0.923271630085233
down	RALB; PPP2CA; PIH1D1;	GO:0071902~positive regulation of protein serine/threonine kinase activity	3	51	5.88235294117647	0.0202355058627743	0.113335349838901	1	1	0.908713629785682	0.99099425631235	0.923271630085233
down	SAP18; CREG1; CDYL;	GO:1903507~negative regulation of nucleic acid-templated transcription	3	51	5.88235294117647	0.0202355058627743	0.113335349838901	1	1	0.908713629785682	0.99099425631235	0.923271630085233
up	TLR4; VGF; HP; LYZ; IRF8; CEBPE; COLEC12; DEFB108B; NLRP1; NLRC4; STAB1; ADAMTS5; NOD1; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-13; IGHG1; IGHV1-2; IGHV3-30; IGHA2; IGLC2; IGHV2-5; IGHD; IGHV3-49; IGHV1-18; IGHV3-7; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-23; HAMP; IGHV1-69-2; TRDC; IGHV4-61; IGKC; IGHV4-39; IGHM; IGHV4-4; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	46	216	21.2962962962963	0.0207833911726392	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	DRD5; AVPR1A; AVPR1B; AVPR2;	GO:0001992~regulation of systemic arterial blood pressure by vasopressin	4	5	80	0.0209095256018161	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	CNR2; MILR1; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	4	5	80	0.0209095256018161	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	SCIMP; PIK3AP1; UNC93B1; TLR7;	GO:0034154~toll-like receptor 7 signaling pathway	4	5	80	0.0209095256018161	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	PLA2G2A; S100A7; ITLN1;	GO:0019730~antimicrobial humoral response	3	52	5.76923076923077	0.021236648799954	0.113335349838901	1	1	0.913175898398023	0.99099425631235	0.923271630085233
up	HLA-F; HLA-C; HLA-A; HLA-B; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	6	12	50	0.0222272002937818	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	HLA-B; HLA-A; HLA-C; HLA-H; FCGRT; HLA-F;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	6	12	50	0.0222272002937818	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	CD4; ADCYAP1R1; TRPC3; P2RX5; P2RX4; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	6	12	50	0.0222272002937818	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	FCMR; BCL10; ITK;	GO:0006968~cellular defense response	3	53	5.66037735849057	0.0222644887463965	0.117831460933798	1	1	0.916900239063031	0.99099425631235	0.959898612095087
down	CCR7; CXCR4; LEF1;	GO:0071345~cellular response to cytokine stimulus	3	53	5.66037735849057	0.0222644887463965	0.117831460933798	1	1	0.916900239063031	0.99099425631235	0.959898612095087
down	COL3A1; NME2; ITGA11; ITGBL1;	GO:0007229~integrin-mediated signaling pathway	4	96	4.16666666666667	0.0227924335652445	0.120296849634547	1	1	0.91993231657316	0.99099425631235	0.979982579257754
down	TGFA; FYN; FGF2; PSMC6; RASA3; PEA15; GFRA4;	GO:0000165~MAPK cascade	7	254	2.75590551181102	0.0232145247632557	0.122191669745724	1	1	0.923137655655296	0.99099425631235	0.995418483900492
up	ADCY3; RAMP3; CALCA; PTH; DRD1; DRD5; GLP1R; ADCY7; CXCL9; ADCY2; GPR65; UCN2; GPHA2; CALCB; ADGRE1; ADGRG5; ADGRE2; ADGRE3; PTGER1; FSHR; PTGDR; ADGRG7; ADGRG1; ADGRE4P; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	25	103	24.2718446601942	0.0237942317492713	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	CLTA; CTSE; CAPZB; RAB7A;	GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II	4	98	4.08163265306122	0.0242974169076493	0.127544977100587	1	1	0.926531544095206	0.99099425631235	1
down	EDEM1; TSPYL2; DNAJB9;	GO:0036498~IRE1-mediated unfolded protein response	3	55	5.45454545454545	0.0244002537853468	0.127738625897883	1	1	0.927209643843179	0.99099425631235	1
down	CILP; STC2; FYN; FGF2; CD28; EMILIN1;	GO:0010629~negative regulation of gene expression	6	204	2.94117647058824	0.0262989236838601	0.129580914192125	1	1	0.937025466666191	0.99099425631235	1
down	NGF; PLCL1; PLCD3;	GO:0048015~phosphatidylinositol-mediated signaling	3	57	5.26315789473684	0.026642687165207	0.129580914192125	1	1	0.937025466666191	0.99099425631235	1
up	HLA-B; HLA-H; HLA-A; HLA-C; HLA-F;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	5	9	55.5555555555556	0.0269225637292123	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	TLR4; FGF10; RAMP3; EGFR; PDGFB; CD4; CSF1R; ALOX15; CD36; FGFR2; FSHR; ARRB2; CCR1; FLT4; CHRNA7; THPO; CASR; NOTCH1; P2RY1; TIRAP; SLAMF1; AGER; ANGPT1; SYT14P1; SCIMP; SLC30A10; GCNT2; NOX4; NOD1; GPR55; MFHAS1; CCL11; CCL4; CCL5; HMGB1P1; XCL1; CCL24; CCL14; XCL2; CCL13; CCL26; NTRK2; CCL18; CCL16;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	44	209	21.0526315789474	0.0269520222418057	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	CD19; FCGR2B; TCIRG1; IL13RA2; INPP5D; TLR8;	GO:0016064~immunoglobulin mediated immune response	6	13	46.1538461538462	0.0289952697007201	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	FGF2; S100A12; TENM1;	GO:0043406~positive regulation of MAP kinase activity	3	60	5	0.0302057079776203	0.129580914192125	1	1	0.946773348518493	0.99099425631235	1
down	SPARC; BMP6; IL22;	GO:0051384~response to glucocorticoid	3	60	5	0.0302057079776203	0.129580914192125	1	1	0.946773348518493	0.99099425631235	1
up	LAT; SELE; AVPR1A; CCR6; HPCA; BTK; TPCN2; TRPM4; SGCD; P2RY11; CAMKK2; P2RX4; LAT2; P2RY12; NMUR1; PTGDR2; CCR2; CCR1; CALML6; CXCR3; SAMD14;	GO:0019722~calcium-mediated signaling	21	85	24.7058823529412	0.0312582708204392	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	TLR4; CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.0313171030227153	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0323885400172641	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	FYN; ARF4; ARC;	GO:0007612~learning	3	62	4.83870967741935	0.0327133081018123	0.132287427543237	1	1	0.948813808321335	0.99099425631235	1
down	CREG1; PPP2CA; BCL2L1;	GO:0040008~regulation of growth	3	62	4.83870967741935	0.0327133081018123	0.132287427543237	1	1	0.948813808321335	0.99099425631235	1
down	KLK8; NGF; NYAP2;	GO:0048812~neuron projection morphogenesis	3	62	4.83870967741935	0.0327133081018123	0.132287427543237	1	1	0.948813808321335	0.99099425631235	1
down	S100A7; S100A12; CXCL2;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	3	62	4.83870967741935	0.0327133081018123	0.132287427543237	1	1	0.948813808321335	0.99099425631235	1
down	FYN; NR4A2; CXCR4; DNER;	GO:0001764~neuron migration	4	109	3.6697247706422	0.0336339206372593	0.13558250039846	1	1	0.949943348569336	0.99099425631235	1
down	ARF4; S1PR1; ACAT1; UFC1; CXCR4; CDH2;	GO:0007420~brain development	6	217	2.76497695852535	0.0338119936132212	0.13587931873197	1	1	0.949943348569336	0.99099425631235	1
down	ADD2; DNER; CDH2;	GO:0007416~synapse assembly	3	63	4.76190476190476	0.0340065626411846	0.136378285374689	1	1	0.951156558465338	0.99099425631235	1
down	MB; ETS1; NR4A2; CXCR4; MMP2;	GO:0001666~response to hypoxia	5	163	3.06748466257669	0.0352389719444348	0.13882792480091	1	1	0.95145224249974	0.99099425631235	1
down	SAT1; TCF7; PLCD3; GNL3; FYN;	GO:0042127~regulation of cell population proliferation	5	163	3.06748466257669	0.0352389719444348	0.13882792480091	1	1	0.95145224249974	0.99099425631235	1
up	TLR4; IL18RAP; AVPR2; LILRB1; IL12RB2;	GO:0032609~interferon-gamma production	5	10	50	0.0361595533072622	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	CD28; CASP14; CASP10;	GO:0097190~apoptotic signaling pathway	3	65	4.61538461538462	0.0366715311292114	0.13882792480091	1	1	0.953459809359496	0.99099425631235	1
down	CLDN11; ADAMTS2; FOXA3; CREM; BCL2L1; CCNI; MORN2; PARP11; CDYL;	GO:0007283~spermatogenesis	9	407	2.21130221130221	0.0367717504386645	0.13882792480091	1	1	0.953874148632382	0.99099425631235	1
down	MMP2; TIMP2; MMP13;	GO:0022617~extracellular matrix disassembly	3	66	4.54545454545455	0.0380430424464957	0.13882792480091	1	1	0.953874148632382	0.99099425631235	1
down	TRBJ2-1; BCL10; ARG1; FYN; ARG2; ITK; CAMK4; RNF125;	GO:0002250~adaptive immune response	8	347	2.30547550432277	0.0388035408246886	0.13882792480091	1	1	0.955402793101344	0.99099425631235	1
down	EIF2S2; ADD2; PSMC6; SLC22A25; SLC35F2; ABCG2; ABCC13;	GO:0055085~transmembrane transport	7	285	2.45614035087719	0.0390133243408496	0.13882792480091	1	1	0.955402793101344	0.99099425631235	1
down	ARG1; ETS1; PPIF;	GO:0070301~cellular response to hydrogen peroxide	3	67	4.47761194029851	0.0394404246151974	0.13882792480091	1	1	0.955402793101344	0.99099425631235	1
up	CACNB4; TRPM2; ITGAV; CHRNA7; PKD1; CACNB1; CACNG1; TRPC3; PKD2; TRPV1; TRPM4; PKD1L1; ATP2A3; ORAI1; ORAI2; P2RX4; P2RX7; TRPM6; P2RY12; CACNA2D2; PKD2L2; TRPC4; TRPC5; TRPV2; ATP2A1; ATP2C2;	GO:0070588~calcium ion transmembrane transport	26	115	22.6086956521739	0.040972485640773	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	IL11; NR4A2; NR4A3;	GO:0045444~fat cell differentiation	3	70	4.28571428571429	0.0437865716220979	0.142785503757582	1	1	0.960862237633352	0.99099425631235	1
up	SCT; SCTR; AQP4; CLN3;	GO:0009992~cellular water homeostasis	4	7	57.1428571428571	0.0442523864845777	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	PLA2G6; PGS1; SLC27A1; PTPMT1;	GO:0032049~cardiolipin biosynthetic process	4	7	57.1428571428571	0.0442523864845777	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	POMC; SCT; SCTR; HTR4;	GO:0032098~regulation of appetite	4	7	57.1428571428571	0.0442523864845777	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	FCGR2B; TBC1D10C; FOXJ1; BANK1;	GO:0050869~negative regulation of B cell activation	4	7	57.1428571428571	0.0442523864845777	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	FGF10; WNT7B; PKD1; FOXJ1;	GO:0060428~lung epithelium development	4	7	57.1428571428571	0.0442523864845777	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
up	CYP7B1; TNC; NOTCH1; ID4;	GO:0060740~prostate gland epithelium morphogenesis	4	7	57.1428571428571	0.0442523864845777	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	FGF2; GAL; BEX1; NINJ2; TENM1; NAV3; GFRA4;	GO:0007399~nervous system development	7	294	2.38095238095238	0.0446591538971446	0.144170511473597	1	1	0.960862237633352	0.99099425631235	1
down	CDK7; POLR2K; PAF1;	GO:0006368~transcription elongation from RNA polymerase II promoter	3	71	4.22535211267606	0.0452861799331457	0.144170511473597	1	1	0.960862237633352	0.99099425631235	1
down	EDEM1; DNAJB9; PSMC6;	GO:0030433~ubiquitin-dependent ERAD pathway	3	71	4.22535211267606	0.0452861799331457	0.144170511473597	1	1	0.960862237633352	0.99099425631235	1
down	FYN; ARC; NGF;	GO:0050804~modulation of chemical synaptic transmission	3	71	4.22535211267606	0.0452861799331457	0.144170511473597	1	1	0.960862237633352	0.99099425631235	1
up	PLA2G6; KNG1; CALCA; ITGAV; CD36; GATA2; CCR1; AVPR1A; GLP1R; P2RY1; AVPR1B; GIPR; P2RY4; CAV3; DLG4; PKD1; ITPR3; PLCZ1; TRPM4; C1QTNF1; HRH4; GPR35; TRPC5; PTGDR; FPR3; CMKLR1; TAC4; PTGER1; CXCR3; CCR6; CCR2; C3AR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	32	150	21.3333333333333	0.0461441896709263	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	IL11; CEBPG; DNAJB9;	GO:0030183~B cell differentiation	3	72	4.16666666666667	0.0468109985748857	0.144170511473597	1	1	0.963046015446155	0.99099425631235	1
down	BCL10; PTTG1IP; PHF23;	GO:0031398~positive regulation of protein ubiquitination	3	72	4.16666666666667	0.0468109985748857	0.144170511473597	1	1	0.963046015446155	0.99099425631235	1
up	ARID1A; PABPC1L; KMT2B; PADI2; ZMIZ2;	GO:0048096~chromatin-mediated maintenance of transcription	5	11	45.4545454545455	0.0471181735154256	0.999999975761346	1	1	0.999999975761346	0.999999975761346	1
down	RAB24; NRBF2; PHF23; MAP1LC3B;	GO:0006914~autophagy	4	123	3.2520325203252	0.0481512541060953	0.144170511473597	1	1	0.963046015446155	0.99099425631235	1
down	ARG1; FGF2; BMP6;	GO:0001938~positive regulation of endothelial cell proliferation	3	73	4.10958904109589	0.0483608770625068	0.144170511473597	1	1	0.965459664607674	0.99099425631235	1
down	RPA2; CDK7; POLR2K;	GO:0006283~transcription-coupled nucleotide-excision repair	3	73	4.10958904109589	0.0483608770625068	0.144170511473597	1	1	0.965459664607674	0.99099425631235	1
down	FYN; TPT1; SARAF;	GO:0006816~calcium ion transport	3	74	4.05405405405405	0.0499356592745741	0.144170511473597	1	1	0.965459664607674	0.99099425631235	1
down	LEF1; CXCR4; CCR7;	GO:0060326~cell chemotaxis	3	74	4.05405405405405	0.0499356592745741	0.144170511473597	1	1	0.965459664607674	0.99099425631235	1
